The Tango of Immune and Neural Cells: Orchestrating Neuroinflammation Mediated Brain Disorders
-
By
-
Wu, Yimao
-
Lyu, Weiqi
-
Xie, Xiaofei
-
Fu, Xiao
-
Zhang, Liao
-
Pan, Junfu
-
May 11, 2026
-
Clinical Scorecard: The Interplay Between Immune and Neural Cells: Managing Neuroinflammation in Brain Disorders
At a Glance
| Category | Detail |
|---|
| Condition | Neuroinflammation in brain disorders |
| Key Mechanisms | Bidirectional interaction between immune cells and neural cells affecting CNS homeostasis and disease progression. |
| Target Population | Patients with neurological disorders such as Alzheimer's disease, Parkinson's disease, depression, and schizophrenia. |
| Care Setting | Clinical settings focusing on neurological health and disease management. |
Key Highlights
- Neuroinflammation is driven by dysregulated immune-neural crosstalk.
- Common inflammatory features include glial cell activation and BBB damage.
- Emerging interventions include immunometabolic regulation and cell therapy.
- Clinical translation efforts focus on biomarkers and targeted therapies.
- Future research aims to enhance understanding of immune-neural interactions.
Guideline-Based Recommendations
Diagnosis
- Utilize biomarkers for accurate diagnosis of neuroinflammatory conditions.
Management
- Target both immune and neural cells in therapeutic strategies.
Monitoring & Follow-up
- Assess spatiotemporal dynamics of immune-neural interactions.
Risks
- Consider potential for impaired neuronal function and BBB integrity.
Patient & Prescribing Data
Individuals diagnosed with neuroinflammatory brain disorders.
Focus on therapies that modulate immune responses and support neuronal health.
Clinical Best Practices
- Integrate interdisciplinary approaches in research and treatment.
- Monitor for disease-specific pathological mechanisms alongside common features.
Related Resources & Content
